Skip to main content

Sudden Cardiac Death and Congestive Heart Failure: Diagnosis and Treatment

Proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA, October 26 and 27, 1982

  • Conference proceedings
  • © 1983

Overview

Part of the book series: Developments in Cardiovascular Medicine (DICM, volume 25)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (28 papers)

  1. New Antiarrhythmic Agents: Basic Considerations

  2. Efficacy Models for Patients with Chronic Ventricular Arrhythmias

  3. Sudden Death: Can it Now be Used as an Endpoint?

  4. New Devices: Pacemakers in the Treatment of Arrhythmias and Prevention of Sudden Cardiac Death

Keywords

About this book

In Harch of 1980, we organized the first symposium on how to evaluate new antiarrhythmic agents in which the participants included members of the Cardio-Renal Division of the Food and Drug Administration, academic investigators from the United States and Abroad and directors and imple­ mentors of pharmacological research representing the pharmaceutical industry. By bringing together all three elements, it was hoped that better communication and under­ standing would ensue to more rapidly bring new cardiac agents to the American public. This goal was important since a rather limited number of antiarrhythmic agents were and are currently available to treat patients with such disorders in the United States. These agents are needed not only for the treatment of patients with sustained ventricular tachyarrhythmias which produce life-threatening hemodynamic consequences but also and in fact more potentially important as a prophylactic measure in the high risk patient subject to sudden cardiac death. This book represents the proceedings of the third of these Symposiums whose purpose was to evaluate the clinical research methodology and models used in the evaluation of ne" antiarrhythmic agents for not only acute therapeutic inter­ vention but also for the prophylaxis of sudden cardiac death. In addition, new devices have evolved over the past few years that can detect and treat life-threatening cardiac arrhythmias and the evaluation of efficacy and safety of these devices is detailed.

Editors and Affiliations

  • Likoff Cardiovascular Institute of Hahnemann Medical College and Hospital, Philadelphia, USA

    J. Morganroth

  • School of Veterinary Medicine, University of Pennsylvania, Philadelphia, USA

    E. Neil Moore

Bibliographic Information

  • Book Title: Sudden Cardiac Death and Congestive Heart Failure: Diagnosis and Treatment

  • Book Subtitle: Proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA, October 26 and 27, 1982

  • Editors: J. Morganroth, E. Neil Moore

  • Series Title: Developments in Cardiovascular Medicine

  • DOI: https://doi.org/10.1007/978-1-4613-3876-5

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Martinus Nijhoff Publishers, Boston 1983

  • Hardcover ISBN: 978-0-89838-580-9Published: 30 April 1983

  • Softcover ISBN: 978-1-4613-3878-9Published: 13 October 2011

  • eBook ISBN: 978-1-4613-3876-5Published: 06 December 2012

  • Series ISSN: 0166-9842

  • Edition Number: 1

  • Number of Pages: XVI, 302

  • Topics: Cardiology

Publish with us